Neonc Technologies Holdings, Inc.
NASDAQ: NTHI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Amir Farrokh Heshmatpour
- Employees
- 8
- Headquarters
- Calabasas, United States
- IPO year
- 2025
- Market cap
- $94.2M
- Website
- https://www.neonctech.com
Loading NTHI…
Loading profile data…Frequently asked questions about NTHI
What does Neonc Technologies Holdings, Inc. (NTHI) do?
Neonc Technologies Holdings, Inc. specializes in pioneering molecular advancements aimed at improving the targeted administration of therapies for central nervous system disorders. The company's leading pipeline candidate, NEO100, is presently undergoing Phase 2a clinical trials for the treatment of glioblastoma. Additionally, NEO212, a unique m...
Where does NTHI trade?
Neonc Technologies Holdings, Inc. (NTHI) trades on the NASDAQ Global Select.
What sector is NTHI in?
Neonc Technologies Holdings, Inc. (NTHI) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Neonc Technologies Holdings, Inc.?
Amir Farrokh Heshmatpour is the chief executive officer of Neonc Technologies Holdings, Inc. (NTHI).
Where is Neonc Technologies Holdings, Inc. headquartered?
Neonc Technologies Holdings, Inc. is headquartered in United States.
Does NTHI pay a dividend?
Neonc Technologies Holdings, Inc. (NTHI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NTHI go public?
Neonc Technologies Holdings, Inc. (NTHI) completed its initial public offering in 2025.